Functional IOL Implantation in Patients With Epiretinal Membrane
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age20-90
SponsorEye & ENT Hospital of Fudan University
About this trial
We have designed this prospective study to evaluate macular involvement and epiretinal membrane (ERM) grading by OCT in eyes with ERM and to compare clinical outcomes after implantation of Enhance IOL with standard monofocal IOL in eyes with ERM grading preoperatively, aiming to find out whether functional IOL is benefit for patients with ERM.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Requirement for cataract extraction
Age > 40 years
Axial length in 21mm to 25mm
ERM
Disqualifiers
Residual corneal astigmatism > 1.0 D
Amblyopia
Previous ocular surgery
Other ocular pathologies apart from mERM, such as diabetic retinopathy, macular degeneration, glaucoma with field defects
Trial design
Design model
Parallel
Treatments tested in this trial
Intraocular lens implantation
DeviceCataract patients scheduled for surgery will be evaluated by OCT, and those diagnosed with macular epiretinal membrane will be implanted in different IOLs according to the patients' decision: monodical IOL or functional IOL.
Treatment groups
90 Participants
are divided into 2 treatment groupsGroup A: Functional IOLExperimental treatment 1 intervention
Group B: Monofocal IOLOther 1 intervention
Trial outcomes
Primary outcomes
1
UDVA
Uncorrected distance visual acuity
Time frame
1-day/1-week/1-month/3-months/6-monhts/1-year/2-yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov